← Back to headlines





BioNTech Faces Economic Challenges After COVID Vaccine Success
BioNTech, the company behind a major COVID-19 vaccine, is reportedly facing an 'end of an era' as it navigates economic challenges, cuts, and closures after its pandemic-era billions. The company is now placing a significant bet on its cancer research.
14 May, 18:21 — 14 May, 18:21
Coverage Timeline
First report: protothema-en · 14 May, 18:21|Full coverage: 2 · 57m|Window: 57m
Left-leaningCenterRight-leaning
Related Stories

GTA VI Extended Trailer Breaks Viewership Records, Reveals Story Details
56m ago

NASA Prepares to Launch Nancy Grace Roman Space Telescope for Cosmic Discovery
1h ago

Marvell Technology Shares Fall Despite Strong Earnings and AI Guidance
2h ago

Andreessen Horowitz Launches $1.1 Billion AI Infrastructure Fund
2h ago